NEXEL Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Holding
- Established
- 2012-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.nexel.co.kr
A Study of NP-011 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Myocardial Infarction
- Interventions
- Drug: NP-011 (Single Ascending Dose Phase)Drug: NP-011 (Multiple Ascending Dose Phase)Other: NP-011 (Placebo)
- First Posted Date
- 2022-05-24
- Last Posted Date
- 2023-08-03
- Lead Sponsor
- Nexel Co., Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT05387499
- Locations
- 🇦🇺
CMAX Clinical Research Pty Ltd, Adelaide, South Australia, Australia
© Copyright 2025. All Rights Reserved by MedPath